Optiver Holding
HRMY icon

Optiver Holding’s Harmony Biosciences HRMY Stock Holding History

Optiver Holding’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48K Buy
+178
New +$5.62K ﹤0.01% 1885
2025
Q4 		– Sell
-276
Closed -$7.61K – 2688
2025
Q3 		$7.61K Buy
+276
New +$9.51K ﹤0.01% 1460

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's HRMY Position: Q2 2026 in Review

Optiver Holding opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 178 shares worth $6.48K. The stake represents ﹤0.01% of the portfolio and ranks #1885 among its holdings. This is a return to the name: Optiver Holding previously reported a position in HRMY as recently as Q3 2025.

Optiver Holding first reported a position in HRMY in Q3 2025 and has held it in 2 quarters since. The position peaked at $7.61K in Q3 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Optiver Holding held 178 shares of Harmony Biosciences worth $6.48K as of Q2 2026.
  • Harmony Biosciences was a new Optiver Holding position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1885 holding.
  • Optiver Holding first reported a position in Harmony Biosciences in Q3 2025 and has held it in 2 quarters since.
  • Optiver Holding's Harmony Biosciences position peaked at $7.61K in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.